Thailand’s Chulalongkorn University has announced that the country’s second domestically developed vaccine is set to start human trials, and researchers hope to produce up to five million doses of the jab by the end of 2021. The ‘ChulaCov19’ vaccine has proved effective in tests that have been conducted on mice and monkeys, allowing it to proceed to tests on humans either in late April or early May. Announcing the proposed production timeline, Kiat Ruxrungtham, from the Chula Vaccine Research Center, said that “By year-end we should have a production capacity of one to five million doses annually,” suggesting the number could reach as
Hence then, the article about thailand s second domestically developed covid 19 vaccine to start human trials was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Thailand’s second domestically developed Covid-19 vaccine to start human trials )